방법 비교

	Budget Impact Analysis (BIA)	보건 경제학에서의 의사결정 분석 모델링
분야	보건경제학	보건경제학
계열	Process / pipeline	Process / pipeline
기원 연도	2005	1975
창시자	Sullivan, Mauskopf, and colleagues (ISPOR task force)	Pauker & Kassirer (medical decision analysis, Massachusetts General Hospital)
유형	Method	Method
원전	Sullivan, S. D., Mauskopf, J. A., Augustovski, F., et al. (2014). Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value in Health, 17(1), 5-14.	Pauker, S. G., & Kassirer, J. P. (1975). Therapeutic Decision Making: A Cost-Benefit Analysis. New England Journal of Medicine, 293(5), 229-234.
별칭	BIA, financial impact assessment, budget consequence analysis	decision analysis, decision tree, decision model, health economic model
관련	5	5
요약	Budget impact analysis estimates the financial consequences (net costs or savings) of implementing a new health technology in a specific healthcare system or population over a short time horizon (typically 1–5 years). Distinct from cost-effectiveness analysis (which compares health outcomes per dollar), BIA answers a budgetary question: 'If we adopt this new drug/device, how much will it cost our health system next year?' Widely used by hospital procurement committees, insurance formularies, and government health budgets to assess financial feasibility and reimbursement decision.	Decision analytic modeling is a systematic framework for comparing health interventions by integrating evidence on probabilities, outcomes, costs, and patient preferences into a quantitative model. Developed by Pauker and Kassirer in 1975, decision analysis structures clinical uncertainty and economic trade-offs, enabling transparent comparison of treatment options and identification of optimal strategies. Used in health technology assessment, clinical practice guideline development, and resource allocation decisions.